Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture ProcessJan Spanholtz, Harry Dolstra, Frank Preijers et al.|PLoS ONE|2011Cited by 239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia PatientsHarry Dolstra, Nicolaas Schaap, Mieke W.H. Roeven et al.|Clinical Cancer Research|2017Cited by 211
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer ImmunotherapyJan Spanholtz, Harry Dolstra, Marleen Tordoir et al.|PLoS ONE|2010Cited by 183
Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull MiceJeannette Cany, Harry Dolstra, Otto C. Boerman et al.|PLoS ONE|2013Cited by 90
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal CancerJohn P. Veluchamy, Jan Spanholtz, Marleen Tordoir et al.|PLoS ONE|2016Cited by 85